Establishment and internal validation of a model to predict the efficacy of Adalimumab in Crohn's disease.

导出 LinkOut

翻译打印收藏纠错

作者： Fang,Wang ^[1] ; He,Zhou ^[2] ; Yujie,Zhang ^[3] ; Yu,Da ^[2] ; Tiantian,Zhang ^[2] ; Yanting,Shi ^[2] ; Tong,Wu ^[4] ; Jie,Liang ^[5]

作者单位： State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, National Clinical Research Center for Digestive Diseases, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an, China.;Department of Gastroenterology, Fenyang Hospital of Shanxi Province, Fenyang, China. ^[1] State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, National Clinical Research Center for Digestive Diseases, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an, China. ^[2] Department of Histology and Embryology, School of Basic Medicine, Xi'an Medical University, Xi'an, China. ^[3] State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, National Clinical Research Center for Digestive Diseases, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an, China. tongwu0725@fmmu.edu.cn. ^[4] State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, National Clinical Research Center for Digestive Diseases, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an, China. liangjie@fmmu.edu.cn. ^[5]

关键词 Crohn’s disease Nomogram Prediction